Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

Phase 2

6(54.5%)

Phase 3

4(36.4%)

Phase 1

1(9.1%)

11Total

Phase 2(6)

Phase 3(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT06568627Phase 3Recruiting

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Role: lead

NCT06690177Phase 2Not Yet Recruiting

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Role: lead

NCT02278718Phase 3Completed

A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care

Role: lead

NCT04040660Unknown

Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

Role: lead

NCT02148705Phase 3Completed

A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns

Role: lead

NCT03588130Phase 2Completed

A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

Role: lead

NCT04817228Phase 2Completed

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Role: lead

NCT05157763Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Role: lead

NCT00898521Phase 2Completed

Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns

Role: lead

NCT02020746Phase 2Completed

Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds

Role: lead

NCT01350700Completed

Long Term Follow up of Scars Formation and Quality of Life Assessment Study

Role: lead

NCT01679678Phase 2Terminated

A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily Regimen

Role: lead

NCT01800981Unknown

Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care

Role: lead

NCT00324311Phase 3Completed

Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care

Role: lead

All 14 trials loaded